Kellerhals Carrard has advised Sequence SA on obtaining a FinTech Licence from the Swiss Financial Market Supervisory Authority (FINMA), placing the company among only five such licensed institutions in Switzerland.
Eli Lilly agreed to acquire LimmaTech Biologics — a Swiss clinical-stage biotech company developing vaccines for the prevention of life-threatening diseases — for up to USD 780 m in cash, inclusive of an upfront payment and additional potential
Wenger Vieli advised the shareholders of Augenmobil in connection with the acquisition of a majority participation by Vista Augenpraxen & Kliniken. Founded in 2019, Augenmobil provides mobile eye examinations combined with telemedical diagnosis, focusing on ophthalmological
MLL Legal advised DSM Venturing B.V., the corporate venture capital arm of dsm-firmenich, in connection with its role as a new investor within Cosaic’s USD 6 million late seed financing round. Alongside DSM Venturing
Advestra advised Zürcher Kantonalbank as coordinator, agent and lender, as well as the other members of the banking syndicate, on the investment financing for Spitäler Schaffhausen. Together with the subordinated loan from the
Kellerhals Carrard advised Spitäler Schaffhausen (as borrower) on a customized financing transaction including a subordinated credit agreement of CHF 60 million with the Canton Schaffhausen and a credit facility agreement of CHF 100 million with a
Bratschi advised operator Imion in the drafting of customer agreements and connection terms for the development of Leukerbad’s district heating network. The infrastructure will be completed by 2030, with an investment volume of approximately CHF 24
Bär & Karrer has advised Inter IKEA Group on its participation in the Series A financing round of Seprify, a Swiss bio-materials company developing cellulose-based ingredients for industrial applications.
Bär & Karrer acted as lead legal counsel to dsm-firmenich on the completion of its additional listing on SIX Swiss Exchange, where the company's shares now trade under the ticker symbol DSFIR alongside its
Bär & Karrer advised Lighthouse Tech — a Swiss medtech startup based in Ticino that developed Tami, a mobility assistive eyewear frame for people who are blind or visually impaired — throughout completion of its new
